Related Experiment Video
Updated: Jul 13, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Abdominal aortic calcification in patients newly diagnosed with essential thrombocythemia
Myung-Won Lee1, Jeong Suk Koh1, Sora Kang1
1Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Insights
Abdominal aortic calcification (AAC) is prevalent in essential thrombocythemia (ET) patients and linked to arterial thrombotic events. This finding highlights AAC as a significant risk factor in ET, emphasizing the need for its assessment at diagnosis.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Radiology
Background:
- Atherosclerosis is implicated in arterial thrombotic events in essential thrombocythemia (ET).
- Abdominal aortic calcification (AAC) has been understudied in ET patients.
- This study investigated the prevalence and clinical significance of AAC at ET diagnosis.
Purpose of the Study:
- To determine the prevalence of abdominal aortic calcification (AAC) in newly diagnosed essential thrombocythemia (ET) patients.
- To identify risk factors associated with AAC in ET.
- To evaluate the association between AAC and arterial thrombotic vascular events in ET.
Main Methods:
- Retrospective analysis of 94 newly diagnosed ET patients who underwent abdominal computed tomography (CT) between 2002 and 2021.
- Quantitative assessment of abdominal aortic calcification (AAC) using CT imaging.
- Statistical analysis to identify risk factors and associations with thrombotic events.
Main Results:
- Abdominal aortic calcification (AAC) was detected in 66.0% of ET patients.
- Old age, higher white blood cell count, elevated neutrophil-to-lymphocyte ratio, and JAK2V617F positivity were associated with AAC.
- AAC was an independent risk factor for arterial thrombotic vascular events occurring before or at the time of ET diagnosis.
Conclusions:
- Abdominal aortic calcification (AAC) is common in patients with essential thrombocythemia (ET).
- AAC is significantly associated with arterial thrombotic events in ET patients.
- Assessment of AAC may be valuable for risk stratification in ET.
Background:
Although atherosclerosis is likely to be involved in the development of arterial thrombotic events in patients with essential thrombocythemia (ET), abdominal aortic calcification (AAC) has rarely been investigated. We evaluated the prevalence and clinical relevance of AAC at the time of ET diagnosis.
Methods:
This retrospective study included patients newly diagnosed with ET who underwent abdominal computed tomography (CT) at the time of diagnosis between January 2002 and December 2021 at Chungnam National University Hospital, Daejeon, Korea. CT images were reviewed and an aortic calcification score was assigned.
Results:
Of the 94 patients (median age, 62 yr; range, 18‒90 yr), AAC was detected in 62 (66.0%). AAC was most commonly mild (33.0%), followed by moderate (22.7%) and severe (5.3%). Old age [odds ratio (OR), 34.37; 95% confidence interval (CI), 12.32‒95.91; P<0.001] was an independent risk factor for AAC. The patients with AAC had a higher WBC count (11.8±4.7 vs. 9.7±2.9×109/L, P=0.017), higher neutrophil-to-lymphocyte ratio (4.3±2.7 vs. 3.1±1.5, P=0.039), and higher JAK2V617F positivity (81.5% vs. 58.8%, P=0.020) compared to those without AAC. AAC was an independent risk factor for arterial thrombotic vascular events that occurred before or at diagnosis of ET (OR, 4.12; 95% CI, 1.11‒15.85; P=0.034).
Conclusion:
AAC is common in patients with ET and is associated with arterial thrombotic events.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis I: Introduction

